Until Labs is developing reversible cryopreservation technology to extend the viability of donor organs for transplantation and enable whole-body medical hibernation.
- Category
- Organ Cryopreservation
- Stage
- Series A
- Employees
- 37
- HQ
- San Francisco, United States
- Founded
- 2021
- Funding
- $106M